Associations between the Framingham Risk Score and cognitive functions in people with multiple sclerosis

ArticleAçık Erişim

Özet

Background & Objective: Cognitive impairment is common in people with multiple sclerosis (MS). The Framingham Risk Score (FRS) is an algorithm used to estimate the 10-year risk of developing cardiovascular disease (CVDr). This study aimed to evaluate the possible associations between FRS and cognitive impairment in people with MS. Methods: Demographic characteristics, laboratory parameters, clinical findings, vascular risk factors, and Brief International Cognitive Assessment for MS (BICAMS) test results, FRS and CVDr scores were recorded for 110 MS patients. Results: FRS and CVDr scores exhibited a significant negative correlation with the number of correct responses in the Symbol Digit Modalities Test (p < 0.001 for all) and California Verbal Learning Test–Second UK Edition (CVLT-II) test (p < 0.001 for all), and significant positive correlation with the number of incorrect responses in the CVLT-II (p < 0.001 for all). The total score of the Brief Visuospatial Memory Test Revised had a negative correlation with FRS and CVDr (p < 0.001 for both). BICAMS scores showed no significant correlation with smoking status, homocysteine, and uric acid levels. Conclusion: We suppose that vascular risk factors and FRS and CVDr scores may be associated with the deterioration of working memory, information processing speed, verbal learning, and memory in people with MS. Based on the potential impact of vascular risk factors on cognitive functions, our findings suggest that lifestyle changes, appropriate treatment, and using a multidisciplinary approach toward vascular risk factors during MS management may exhibit a positive effect on cognition in people with MS. © 2024, ASEAN Neurological Association. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11420Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.54029/2024rerYayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorErsoy, Alevtina
dc.contributor.authorBaloglu, Senanur
dc.contributor.authorTanoglu, Ceyda
dc.contributor.authorHayme, Serhat
dc.date.accessioned2026-10-18T20:26:28.199706357Z
dc.date.available2026-10-18T20:26:28.199706357Z
dc.date.issued2024
dc.description.abstractBackground & Objective: Cognitive impairment is common in people with multiple sclerosis (MS). The Framingham Risk Score (FRS) is an algorithm used to estimate the 10-year risk of developing cardiovascular disease (CVDr). This study aimed to evaluate the possible associations between FRS and cognitive impairment in people with MS. Methods: Demographic characteristics, laboratory parameters, clinical findings, vascular risk factors, and Brief International Cognitive Assessment for MS (BICAMS) test results, FRS and CVDr scores were recorded for 110 MS patients. Results: FRS and CVDr scores exhibited a significant negative correlation with the number of correct responses in the Symbol Digit Modalities Test (p < 0.001 for all) and California Verbal Learning Test–Second UK Edition (CVLT-II) test (p < 0.001 for all), and significant positive correlation with the number of incorrect responses in the CVLT-II (p < 0.001 for all). The total score of the Brief Visuospatial Memory Test Revised had a negative correlation with FRS and CVDr (p < 0.001 for both). BICAMS scores showed no significant correlation with smoking status, homocysteine, and uric acid levels. Conclusion: We suppose that vascular risk factors and FRS and CVDr scores may be associated with the deterioration of working memory, information processing speed, verbal learning, and memory in people with MS. Based on the potential impact of vascular risk factors on cognitive functions, our findings suggest that lifestyle changes, appropriate treatment, and using a multidisciplinary approach toward vascular risk factors during MS management may exhibit a positive effect on cognition in people with MS. © 2024, ASEAN Neurological Association. All rights reserved.
dc.description.sponsorshipENAGO for linguistic assistance in preparing the article.
dc.identifier.doi10.54029/2024rer
dc.identifier.endpage748
dc.identifier.issn1823-6138
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85208559589
dc.identifier.startpage737
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11420
dc.identifier.volume29
dc.identifier.wosWOS:001403244400026
dc.language.isoen
dc.publisherASEAN Neurological Association
dc.relation.ispartofNeurology Asia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBICAMS
dc.subjectcognition
dc.subjectFramingham Risk Score
dc.subjectMultiple sclerosis
dc.subjectvascular risk factors
dc.subjecthomocysteine
dc.subjecturic acid
dc.subjectadult
dc.subjectannualized rate of relapses
dc.subjectArticle
dc.subjectbody mass
dc.subjectbrief international cognitive assessment for multiple sclerosis
dc.subjectbrief visuospatial memory test revised
dc.subjectcalifornia verbal learning test second uk edition
dc.subjectcardiovascular risk
dc.subjectcognition assessment
dc.subjectcognitive defect
dc.subjectcross-sectional study
dc.subjectdisease duration
dc.subjectepidemiological data
dc.subjectExpanded Disability Status Scale
dc.subjectfemale
dc.subjecthuman
dc.subjectlearning test
dc.subjectmale
dc.subjectmemory assessment
dc.subjectpeople by smoking status
dc.subjectrisk factor
dc.subjectsymbol digit modalities test
dc.subjecttreatment duration
dc.titleAssociations between the Framingham Risk Score and cognitive functions in people with multiple sclerosis
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.oa.statusopen
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)